More European pharmaceutical companies are turning to third-party logistics companies (3PLs) as a cost-cutting measure, according to a new report by healthcare specialists GBI Research. GBI’s new report said there is concern, however, among companies about how to handle these outsourcing efforts. According to the report, direct-to-pharmacy (DTP) and reduced wholesaler agreements (RWA) are gaining prominence in the United Kingdom, but other European Union countri...